Daily Archives: March 20, 2020

FDA Guidance on Clinical Trials During COVID-19 Pandemic

Much attention has been paid to the impact of the COVID-19 pandemic on the supply chain for medicines we rely on, but there has been less focus on the impact of medicines yet to come. The advancements in cancer care … Continue reading

Posted in Clinical Trials, FDA Policy | Tagged | Leave a comment